ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
622.92%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.26 B
According to ImmunoGen 's latest financial reports the company's total liabilities are $0.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ImmunoGen - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | -3.53% |
| 2021-12-31 | $0.20 B | -24.6% |
| 2020-12-31 | $0.26 B | -14.73% |
| 2019-12-31 | $0.31 B | 9.48% |
| 2018-12-31 | $0.28 B | -9.01% |
| 2017-12-31 | $0.31 B | |
| 2016-06-30 | $0.36 B | 32.36% |
| 2015-06-30 | $0.27 B | 204.78% |
| 2014-06-30 | $89.61 M | -2.32% |
| 2013-06-30 | $91.74 M | -4.84% |
| 2012-06-30 | $96.41 M | 24.13% |
| 2011-06-30 | $77.67 M | 120.91% |
| 2010-06-30 | $35.16 M | 3.88% |
| 2009-06-30 | $33.84 M | 20.71% |
| 2008-06-30 | $28.03 M | 27.33% |
| 2007-06-30 | $22.02 M | 1.11% |
| 2006-06-30 | $21.77 M | -6.49% |
| 2005-06-30 | $23.29 M | -8.64% |
| 2004-06-30 | $25.49 M | 66.04% |
| 2003-06-30 | $15.35 M | -14.43% |
| 2002-06-30 | $17.94 M | 7.34% |
| 2001-06-30 | $16.71 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 37,820.19% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 20,850.85% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 52,571.93% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | 20,299.84% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 34,802.21% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 22,015.89% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $65.67 B | 25,110.26% | 🇺🇸 USA |
 Seagen
SGEN | $1.08 B | 316.05% | 🇺🇸 USA |